News | Artificial Intelligence | February 14, 2023

DiA Imaging Analysis’s LVivo IQS - a vendor-neutral AI-powered software solution - provides cardiac ultrasound users with real-time image quality feedback while scanning 

Radiology, the flagship journal of the Radiological Society of North America (RSNA), and the leading journal in the field of medical imaging, will feature special centennial content this year in connection with the publication’s 100th anniversary.

February 14, 2023 —DiA Imaging Analysis, a leading provider of advanced AI-based software solutions for ultrasound image analysis, announced today that the U.S. Food and Drug Administration (FDA) has cleared LVivo IQS, a new AI-based vendor-neutral software solution that enables ultrasound users to acquire high-quality interpretable cardiac ultrasound images that can be used to make better clinical assessments of the heart. 

High-quality cardiac ultrasound image acquisition can be challenging due to the constant motion of the heart and its deep location in the chest, as well as the user expertise that varies between ultrasound users and settings. 

DiA’s new LVivo IQS - Image Quality Score provides real-time image quality feedback while scanning the left ventricle of the heart to assess the heart’s performance. The software uses colors and numerical scoring to indicate the quality level of the image as it is being scanned, helping users to produce optimal interpretable images for more accurate and reproducible analysis of the heart. 

“LVivo IQS is the first of DiA’s 9 FDA-approved software solutions that empowers healthcare professionals with real-time feedback to enable the capture of high-quality ultrasound images,” said Hila Goldman-Aslan, CEO & Founder of DiA Imaging Analysis, “By harnessing the power of AI, our full suite of software solutions helps ultrasound users overcome two major challenges in the field – scanning high-quality images and accurately analyzing them. This holistic approach aligns with our mission of leveraging AI to make ultrasound image capture and analysis processes smarter and more accessible." 

The FDA cleared LVivo IQS following a clinical study that demonstrated its safety and efficacy. The results demonstrated high agreement between the LVivo IQS AI’s quality score feedback and the ability to obtain clinically interpretable images as evaluated by Cardiologist specializing in echocardiography. 91% of images saved by point-of-care residents using LVivo IQS, were found to be clinically interpretable images by the Cardiologist. 

“For precise heart diagnosis and treatment, high-quality cardiac ultrasound imaging is necessary in both point-of-care and other settings," said Dr. Lior Fuchs, Senior Intensive Care Physician at Soroka Medical Center in Israel and principal investigator of the LVivo IQS study.  

"LVivo IQS AI software will assist us in obtaining faster and clearer images to aid our real-time clinical decision-making process.” 


For more information: https://www.dia-analysis.com/ 

Find more ACC23 content here 


Related Content

News | Digital Radiography (DR)

November 26, 2023 — Konica Minolta Healthcare Americas, Inc., announced today several new solutions in digital ...

Time November 26, 2023
arrow
News | RSNA

November 25, 2023 — 4DMedical, a global technology company and producer of advanced lung function imaging software, has ...

Time November 24, 2023
arrow
News | RSNA

November 22, 2023 — GE HealthCare is preparing to showcase its Artificial Intelligence (AI)-enabled solutions at the ...

Time November 22, 2023
arrow
News | RSNA

November 22, 2023 — ScreenPoint Medical has announced that its Transpara breast AI has surpassed 5 million mammograms ...

Time November 22, 2023
arrow
News | FDA

November 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time November 22, 2023
arrow
News | Lung Imaging

November 22, 2023 — Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who ...

Time November 22, 2023
arrow
News | Breast Imaging

November 21, 2023 —iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, and CancerIQ ...

Time November 21, 2023
arrow
News | Artificial Intelligence

November 21, 2023 — A newly developed artificial intelligence (AI) system that analyzes specialized MRIs of the brain ...

Time November 21, 2023
arrow
News | Artificial Intelligence

November 20, 2023 — Enlitic, a pioneering force in the realm of medical imaging data management, is gearing up for its ...

Time November 20, 2023
arrow
News | Enterprise Imaging

November 17, 2023 — Apollo, a leading provider of enterprise imaging solutions and an Amazon Web Services (AWS) Public ...

Time November 17, 2023
arrow
Subscribe Now